Up front, this is not an apples to apples comparative… Travis, a comment you wrote about GAN a number of months ago was spot on. – that being and I paraphrase ‘high risk / high return potential that can decrease into mid single digits and / or increase to $40 – $45 range within 12 months’… GAN has gone the former route underperforming 75% over the past 12 + months, in part due to it being over-hyped, but more so I believe the senior talent within the organization is / was not at an equal match to the market’s over-inflated perceptions of future performance. There seems to be a higher opportunity cost with GAN verses the approach RSI is taking – not as solid technically but staying within boundaries where management can manage and grow… however RSI range has not been stellar as well ($9.5 to $26.5 over the past 12 months) closing January 7, 2022 at $15 USD – both have somewhat outdated targets on YAHOO Finance at $23 for 1 year… which brings Roundhill “BETZ” with a unit price as of close January 7, 2022 being -11% discount to NAV into the discussion… is BETZ a wiser choice to play this space as a short term (6 – 12 months) play?… best of ’22 to all

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.